Alkermes plc (ALKS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.54 |
| Open | 23.85 |
| Bid | 23.98 x 500 |
| Ask | 24.03 x 500 |
| Day's range | 23.26 - 24.28 |
| 52-week range | 22.01 - 33.71 |
| Volume | |
| Avg. volume | 2,033,798 |
| Market cap | 4.062B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 7.85 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Alkermes (ALKS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Zacks
Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
Alkermes (ALKS) delivered earnings and revenue surprises of -25.42% and 2.75%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Investor's Business Daily
How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?
Marc Lichtenfeld, an expert in biotech and income stocks, notes that a lot of Wall Street money moves into companies that issue positive Phase 2 clinical trial data.
© 2024 Yahoo. All rights reserved.